Work

Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies

Year: 2011

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-011-9774-6

Authors: Glen J. Weiss, Manuel Hidalgo, Mitesh J. Borad, Daniel Laheru, Raoul Tibes, Ramesh K. Ramanathan, Lisa Blaydorn, Gayle Jameson, Antonio Jimeno, Jeffrey D. Isaacs, Angela Scaburri, Maria Adele Pacciarini, Francesco Fiorentini, Marina Ciomei, Daniel D. Von Hoff

Institutions: Johns Hopkins University, Mayo Clinic in Arizona, Mayo Clinic Comprehensive Cancer Center (Arizona), University of Colorado Cancer Center, Nerviano Medical Sciences

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Regional Oncology Research Center

OpenAlex ID: W1970888488

FWCI: 1.575

Cites: 38

Cited by: 42

Related to: 10